Drug Type Synthetic peptide |
Synonyms Lung surfactant factor, Lusupultide (INN/USAN), Recombinant surfactant protein C + [3] |
Target |
Mechanism Lipid inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D08943 | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pneumonia | Phase 3 | AU | 01 Nov 2003 | |
Pneumonia | Phase 3 | AT | 01 Nov 2003 | |
Pneumonia | Phase 3 | BE | 01 Nov 2003 | |
Pneumonia | Phase 3 | DK | 01 Nov 2003 | |
Pneumonia | Phase 3 | EE | 01 Nov 2003 | |
Pneumonia | Phase 3 | FI | 01 Nov 2003 | |
Pneumonia | Phase 3 | DE | 01 Nov 2003 | |
Pneumonia | Phase 3 | GR | 01 Nov 2003 | |
Pneumonia | Phase 3 | HU | 01 Nov 2003 | |
Pneumonia | Phase 3 | IL | 01 Nov 2003 |
Not Applicable | APC | sEPCR | sTM ... View more | - | (Control group) | lqbqjimaoq(yskfvydoky) = increased htyrojrsby (fpbpbtzdcg ) View more | Positive | 30 Oct 2012 | |
(PC activation group (Ad-FLT-1/PC transfected+thrombin; APC)) |